Neocis has raised $72 million in a funding round that will support the continued marketing of Yomi, the company's robotic-assisted dental surgery system.
The funding round was led by DFJ Growth and included Vivo Capital and existing Neocis investors Mithril Capital Management, Norwest Venture Partners, Section 32, and Fred Moll.
Yomi has received clearance from the U.S. Food and Drug Administration (FDA), and has been used to place more than 2,700 dental implants, according to the firm. It is in use at Boston University Henry M. Goldman School of Dental Medicine and the West Virginia University School of Dentistry in Morgantown.
Neocis was founded in 2009 and has raised $120 million in financing since its inception, the company said.
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.hpp4JFpXkV.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
